These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

366 related items for PubMed ID: 27427521

  • 1. Stereotactic Body Radiation Therapy for Stage I Non-Small Cell Lung Cancer.
    Aridgides P, Bogart J.
    Thorac Surg Clin; 2016 Aug; 26(3):261-9. PubMed ID: 27427521
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Phase 2 Study of Stereotactic Body Radiation Therapy and Stereotactic Body Proton Therapy for High-Risk, Medically Inoperable, Early-Stage Non-Small Cell Lung Cancer.
    Nantavithya C, Gomez DR, Wei X, Komaki R, Liao Z, Lin SH, Jeter M, Nguyen QN, Li H, Zhang X, Poenisch F, Zhu XR, Balter PA, Feng L, Choi NC, Mohan R, Chang JY.
    Int J Radiat Oncol Biol Phys; 2018 Jul 01; 101(3):558-563. PubMed ID: 29680255
    [Abstract] [Full Text] [Related]

  • 4. Surgery versus stereotactic body radiation therapy for stage I non-small cell lung cancer: A comprehensive review.
    Tandberg DJ, Tong BC, Ackerson BG, Kelsey CR.
    Cancer; 2018 Feb 15; 124(4):667-678. PubMed ID: 29266226
    [Abstract] [Full Text] [Related]

  • 5. Stereotactic body radiation therapy versus no treatment for early stage non-small cell lung cancer in medically inoperable elderly patients: A National Cancer Data Base analysis.
    Nanda RH, Liu Y, Gillespie TW, Mikell JL, Ramalingam SS, Fernandez FG, Curran WJ, Lipscomb J, Higgins KA.
    Cancer; 2015 Dec 01; 121(23):4222-30. PubMed ID: 26348268
    [Abstract] [Full Text] [Related]

  • 6. Stereotactic body radiation therapy versus conventional radiation therapy in patients with early stage non-small cell lung cancer: an updated retrospective study on local failure and survival rates.
    Jeppesen SS, Schytte T, Jensen HR, Brink C, Hansen O.
    Acta Oncol; 2013 Oct 01; 52(7):1552-8. PubMed ID: 23902274
    [Abstract] [Full Text] [Related]

  • 7. The impact of tumor size on outcomes after stereotactic body radiation therapy for medically inoperable early-stage non-small cell lung cancer.
    Allibhai Z, Taremi M, Bezjak A, Brade A, Hope AJ, Sun A, Cho BC.
    Int J Radiat Oncol Biol Phys; 2013 Dec 01; 87(5):1064-70. PubMed ID: 24210082
    [Abstract] [Full Text] [Related]

  • 8. Stereotactic body radiation therapy (SBRT) for early-stage lung cancer in the elderly.
    Shinde A, Li R, Kim J, Salgia R, Hurria A, Amini A.
    Semin Oncol; 2018 Aug 01; 45(4):210-219. PubMed ID: 30286944
    [Abstract] [Full Text] [Related]

  • 9. Cost-effectiveness analysis of stereotactic body radiotherapy and surgery for medically operable early stage non small cell lung cancer.
    Paix A, Noel G, Falcoz PE, Levy P.
    Radiother Oncol; 2018 Sep 01; 128(3):534-540. PubMed ID: 29706462
    [Abstract] [Full Text] [Related]

  • 10. Stereotactic body radiation therapy (stereotactic ablative radiotherapy) for stage I non-small cell lung cancer--updates of radiobiology, techniques, and clinical outcomes.
    Hadziahmetovic M, Loo BW, Timmerman RD, Mayr NA, Wang JZ, Huang Z, Grecula JC, Lo SS.
    Discov Med; 2010 May 01; 9(48):411-7. PubMed ID: 20515609
    [Abstract] [Full Text] [Related]

  • 11. Comparison of outcomes following stereotactic body radiotherapy for non-small cell lung cancer in patients with and without pathological confirmation.
    Haidar YM, Rahn DA, Nath S, Song W, Bazhenova L, Makani S, Fuster MM, Sandhu AP.
    Ther Adv Respir Dis; 2014 Feb 01; 8(1):3-12. PubMed ID: 24334338
    [Abstract] [Full Text] [Related]

  • 12. Risk-adapted robotic stereotactic body radiation therapy for inoperable early-stage non-small-cell lung cancer.
    Temming S, Kocher M, Stoelben E, Hagmeyer L, Chang DH, Frank K, Hekmat K, Wolf J, Baus WW, Semrau R, Baues C, Marnitz S.
    Strahlenther Onkol; 2018 Feb 01; 194(2):91-97. PubMed ID: 28812120
    [Abstract] [Full Text] [Related]

  • 13. Stereotactic body radiation therapy (SBRT) for early-stage lung cancer.
    Hiraoka M, Matsuo Y, Nagata Y.
    Cancer Radiother; 2007 Feb 01; 11(1-2):32-5. PubMed ID: 17158081
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Stereotactic body radiation therapy for early-stage non-small cell lung cancer: Executive Summary of an ASTRO Evidence-Based Guideline.
    Videtic GMM, Donington J, Giuliani M, Heinzerling J, Karas TZ, Kelsey CR, Lally BE, Latzka K, Lo SS, Moghanaki D, Movsas B, Rimner A, Roach M, Rodrigues G, Shirvani SM, Simone CB, Timmerman R, Daly ME.
    Pract Radiat Oncol; 2017 Feb 01; 7(5):295-301. PubMed ID: 28596092
    [Abstract] [Full Text] [Related]

  • 16. Stereotactic Ablative Radiotherapy as an Alternative to Lobectomy in Patients With Medically Operable Stage I NSCLC: A Retrospective, Multicenter Analysis.
    Scotti V, Bruni A, Francolini G, Perna M, Vasilyeva P, Loi M, Simontacchi G, Viggiano D, Lanfranchi B, Gonfiotti A, Topulli J, Olmetto E, Maragna V, Ferrari K, Bonti V, Comin C, Balduzzi S, D'Amico R, Lohr F, Voltolini L, Livi L.
    Clin Lung Cancer; 2019 Jan 01; 20(1):e53-e61. PubMed ID: 30348595
    [Abstract] [Full Text] [Related]

  • 17. Stereotactic body radiotherapy versus surgery for medically operable Stage I non-small-cell lung cancer: a Markov model-based decision analysis.
    Louie AV, Rodrigues G, Hannouf M, Zaric GS, Palma DA, Cao JQ, Yaremko BP, Malthaner R, Mocanu JD.
    Int J Radiat Oncol Biol Phys; 2011 Nov 15; 81(4):964-73. PubMed ID: 20932688
    [Abstract] [Full Text] [Related]

  • 18. Canadian Phase III Randomized Trial of Stereotactic Body Radiotherapy Versus Conventionally Hypofractionated Radiotherapy for Stage I, Medically Inoperable Non-Small-Cell Lung Cancer - Rationale and Protocol Design for the Ontario Clinical Oncology Group (OCOG)-LUSTRE Trial.
    Swaminath A, Wierzbicki M, Parpia S, Wright JR, Tsakiridis TK, Okawara GS, Kundapur V, Bujold A, Ahmed N, Hirmiz K, Kurien E, Filion E, Gabos Z, Faria S, Louie AV, Owen T, Wai E, Ramchandar K, Chan EK, Julian J, Cline K, Whelan TJ.
    Clin Lung Cancer; 2017 Mar 15; 18(2):250-254. PubMed ID: 27876603
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. The role of stereotactic body radiotherapy in the management of non-small cell lung cancer: an emerging standard for the medically inoperable patient?
    Videtic GM, Stephans KL.
    Curr Oncol Rep; 2010 Jul 15; 12(4):235-41. PubMed ID: 20446066
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 19.